Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3050% below fair value
$0.74−0.00 (-0.43%)
Close on Nov 17, 2026Market cap $36.96MP/E –Yield –
Rapid Micro Biosystems operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Rapid Micro Biosystems's operating income for the twelve months ending Jun 30, 2026 was -$49.76M. For fiscal 2025 it was -$47.39M. The highest annual figure on record is -$30.54M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$47.39M | – |
| FY2024 | Dec 31, 2024 | -$49.92M | – |
| FY2023 | Dec 31, 2023 | -$56.56M | – |
| FY2022 | Dec 31, 2022 | -$63.22M | – |
| FY2021 | Dec 31, 2021 | -$47.23M | – |
| FY2020 | Dec 31, 2020 | -$30.54M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.32M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.21M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.04M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.87M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.26M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.07M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.00M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.56M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.12M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.86M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.72M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.01M | – |
See a number that looks wrong?